Douglas Shytle

Title: Douglas Shytle: Innovator in Pharmaceutical Composition

Introduction

Douglas Shytle is a notable inventor based in Lutz, Florida, recognized for his contributions to pharmaceutical compositions. He holds a total of 5 patents, showcasing his innovative approach to addressing various medical conditions through his research and inventions.

Latest Patents

One of his latest patents is focused on the formulation and use of exo-S-mecamylamine in treatment. This pharmaceutical composition includes a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, which is substantially free of exo-R-mecamylamine. The formulation is designed to treat a range of medical conditions, including substance addiction, smoking cessation, hypertension, Tourette's Syndrome, cancer, neuropsychiatric disorders, chronic fatigue syndrome, and more. The preferred dosage ranges from about 0.5 mg to about 20 mg, providing a versatile solution for various health issues.

Career Highlights

Douglas Shytle is affiliated with the University of South Florida, where he continues to advance his research in pharmaceutical sciences. His work has significantly impacted the field, particularly in developing treatments for complex medical conditions.

Collaborations

He collaborates with esteemed colleagues such as Paul R. Sanberg and Mary Newman, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Douglas Shytle's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research efforts are paving the way for new treatments that can improve the quality of life for many individuals facing challenging health conditions.